FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309047633> ?p ?o ?g. }

• W4309047633 endingPage "248" @default.
• W4309047633 startingPage "239" @default.
• W4309047633 abstract "Enhancement of skin permeation of drugs is affected by the simultaneous co-permeation of excipients that hinder the predictivity of in vitro tests. The collaborative effects of two permeation enhancers (ethanol and d-limonene) of a lipophilic drug (alprazolam) have been simultaneously assessed in human skin under different in vitro conditions: integrated setups of diffusion cell experiments with selective concentration gradients of permeants (asymmetric) or without (symmetric) have been combined with coadministration dosages (all-in-one) at different concentrations or short-time skin pretreatment to scrutiny this mutual performance. Findings: Drug permeation is increased under moderated supersaturation but reaches a stationary level above 33 % of its solubility. Ethanol in absence of a concentration gradient increases ca.5 times basal drug permeation. Limonene until 20 % permeates human skin proportionally to its donor concentration but its effect does not depend on ethanol in symmetric conditions and is based on skin imbibition rather than on a carry-on effect. Simultaneous permeation of ethanol and limonene reaches a stationary state after 1.5 h, enough time to achieve maximal enhancement of alprazolam permeation. Additive enhancement is based on ethanol solubilisation maximized by skin saturation of terpene. Complementary analyses of skin disruption published in the literature are in line with these assessments and consolidate them." @default.
• W4309047633 created "2022-11-21" @default.
• W4309047633 creator A5006480987 @default.
• W4309047633 creator A5038559257 @default.
• W4309047633 creator A5076048039 @default.
• W4309047633 creator A5082032209 @default.
• W4309047633 date "2022-12-01" @default.
• W4309047633 modified "2023-10-16" @default.
• W4309047633 title "Collaborative permeation of drug and excipients in transdermal formulations. In vitro scrutiny for ethanol:limonene combinations" @default.
• W4309047633 cites W1550353272 @default.
• W4309047633 cites W1568007316 @default.
• W4309047633 cites W1576072987 @default.
• W4309047633 cites W1965935677 @default.
• W4309047633 cites W1972471925 @default.
• W4309047633 cites W1973434781 @default.
• W4309047633 cites W1976746423 @default.
• W4309047633 cites W1980895592 @default.
• W4309047633 cites W1982205525 @default.
• W4309047633 cites W1983122413 @default.
• W4309047633 cites W1989220971 @default.
• W4309047633 cites W1999554610 @default.
• W4309047633 cites W2002218627 @default.
• W4309047633 cites W2007249172 @default.
• W4309047633 cites W2014088062 @default.
• W4309047633 cites W2014092938 @default.
• W4309047633 cites W2026873054 @default.
• W4309047633 cites W2032728552 @default.
• W4309047633 cites W2035726613 @default.
• W4309047633 cites W2040982817 @default.
• W4309047633 cites W2046150242 @default.
• W4309047633 cites W2049003027 @default.
• W4309047633 cites W2051126184 @default.
• W4309047633 cites W2053828559 @default.
• W4309047633 cites W2064182421 @default.
• W4309047633 cites W2064842276 @default.
• W4309047633 cites W2067857128 @default.
• W4309047633 cites W2069173907 @default.
• W4309047633 cites W2071957890 @default.
• W4309047633 cites W2071975402 @default.
• W4309047633 cites W2077122782 @default.
• W4309047633 cites W2078500447 @default.
• W4309047633 cites W2078936639 @default.
• W4309047633 cites W2086907920 @default.
• W4309047633 cites W2090425883 @default.
• W4309047633 cites W2093037613 @default.
• W4309047633 cites W2093685319 @default.
• W4309047633 cites W2109833305 @default.
• W4309047633 cites W2111511285 @default.
• W4309047633 cites W2145090259 @default.
• W4309047633 cites W2317186183 @default.
• W4309047633 cites W2322453335 @default.
• W4309047633 cites W2325239247 @default.
• W4309047633 cites W2769616543 @default.
• W4309047633 cites W2992295045 @default.
• W4309047633 cites W3197829182 @default.
• W4309047633 cites W36420567 @default.
• W4309047633 cites W4200019735 @default.
• W4309047633 cites W4240821889 @default.
• W4309047633 doi "https://doi.org/10.1016/j.ejpb.2022.11.004" @default.
• W4309047633 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36384197" @default.
• W4309047633 hasPublicationYear "2022" @default.
• W4309047633 type Work @default.
• W4309047633 citedByCount "1" @default.
• W4309047633 countsByYear W43090476332023 @default.
• W4309047633 crossrefType "journal-article" @default.
• W4309047633 hasAuthorship W4309047633A5006480987 @default.
• W4309047633 hasAuthorship W4309047633A5038559257 @default.
• W4309047633 hasAuthorship W4309047633A5076048039 @default.
• W4309047633 hasAuthorship W4309047633A5082032209 @default.
• W4309047633 hasConcept C118552586 @default.
• W4309047633 hasConcept C142724271 @default.
• W4309047633 hasConcept C155574463 @default.
• W4309047633 hasConcept C178790620 @default.
• W4309047633 hasConcept C185592680 @default.
• W4309047633 hasConcept C205679159 @default.
• W4309047633 hasConcept C2777196872 @default.
• W4309047633 hasConcept C2777239854 @default.
• W4309047633 hasConcept C2778370115 @default.
• W4309047633 hasConcept C2780035454 @default.
• W4309047633 hasConcept C2780161600 @default.
• W4309047633 hasConcept C41625074 @default.
• W4309047633 hasConcept C43617362 @default.
• W4309047633 hasConcept C50670333 @default.
• W4309047633 hasConcept C55493867 @default.
• W4309047633 hasConcept C558461103 @default.
• W4309047633 hasConcept C71924100 @default.
• W4309047633 hasConcept C98274493 @default.
• W4309047633 hasConceptScore W4309047633C118552586 @default.
• W4309047633 hasConceptScore W4309047633C142724271 @default.
• W4309047633 hasConceptScore W4309047633C155574463 @default.
• W4309047633 hasConceptScore W4309047633C178790620 @default.
• W4309047633 hasConceptScore W4309047633C185592680 @default.
• W4309047633 hasConceptScore W4309047633C205679159 @default.
• W4309047633 hasConceptScore W4309047633C2777196872 @default.
• W4309047633 hasConceptScore W4309047633C2777239854 @default.
• W4309047633 hasConceptScore W4309047633C2778370115 @default.
• W4309047633 hasConceptScore W4309047633C2780035454 @default.
• W4309047633 hasConceptScore W4309047633C2780161600 @default.

• next